Abstract:Changes in the oxidant/antioxidant environment of aging Leydig cells have been shown to be correlated with the reduced ability of these cells to produce testosterone. We hypothesized that an altered redox environment might result in increased susceptibility to pro-oxidants, and that this might have an impact on steroidogenic function. To begin to test this hypothesis, we experimentally manipulated intracellular glutathione (GSH) concentration in MA-10 Leydig cells, and examined whether the susceptibility of the GSH-depleted cells to oxidative stress was affected. Incubation of MA-10 cells with buthionine sulfoximine (BSO, 100 µM, 18 h) or diethyl maleate (DEM, 200 µM, 30 min) reduced GSH content by more than 70%, while treatment of the cells with 3H-1,2-dithiole-3-thione (D3T, 200 µM, 24 hr) increased the GSH concentration to twice that of the control cells. Depletion of GSH significantly increased the susceptibility of the cells to oxidative stress induced by tert-butyl hydroperoxide (t-BuOOH). In contrast, increasing GSH greatly protected the cells from the same stressor. Thus, the ED50 of progesterone production was reduced from 400 µM t-BuOOH in the control cells to less than 50 µM in GSH-depleted cells. Increasing GSH with D3T greatly increased the ED50 from 400 µM to more than 800 µM. Cell viability, assayed by MTT reduction and ATP production, was significantly affected by t-BuOOH only at concentrations of 100 µM or higher whereas progesterone production was affected by t-BuOOH at much lower (12.5 µM) concentration. Intracellular ROS concentration, as measured by 2, 7-dichlorodihydrofluorescein diacetate (DCF) fluorescence, was significantly increased in GSH-depleted cells in response to t-BuOOH at 50-100 µM. The changes in progesterone and ROS production induced by GSH were prevented by restoration of the cellular GSH pool with glutathione ethyl ester (GSHEE), or by treating the cells with the antioxidant N-acetyl-cysteine (NAC). Two steps of the steroidogenic pathway were particularly sensitive to oxidative stress following GSH depletion: StAR protein synthesis and the conversion of cholesterol to pregnenolone by P450scc within the mitochondria. The results of these studies, taken together, are consistent with the hypothesis that alteration in the oxidant/antioxidant environment may play a significant role in the increased sensitivity of MA-10 cells to pro-oxidant stress, and thus perhaps to the age-related reduced ability of testicular Leydig cells to produce testosterone. Research supported by NIH Grants AG026721 (to H.C.) and AG21092 (to B.R.Z.) from the National Institute on Aging and NIH Training Grant ES07141 (to A.S.M.) from the National Institute of Environmental Health Sciences.

Prevention of Male Late-Onset Hypogonadism by Natural Polyphenolic Antioxidants

Effect of Glutathione Depletion on Susceptibility of Ma-10 Leydig Cell Steroidogenesis to Oxidative Stress

Hallmarks of Testicular Aging: The Challenge of Anti-Inflammatory and Antioxidant Therapies Using Natural and/or Pharmacological Compounds to Improve the Physiopathological Status of the Aged Male Gonad

Age-related testosterone decline: mechanisms and intervention strategies

Influences of flavones on cell viability and cAMP-dependent steroidogenic gene regulation in MA-10 Leydig cells

Humanin Ameliorates Late-onset Hypogonadism in Aged Male Rats

Late-onset hypogonadism: Clinical evidence, biological aspects and evolutionary considerations

Triterpenoids and Polysaccharides from Ganoderma lucidum Improve the Histomorphology and Function of Testes in Middle-Aged Male Mice by Alleviating Oxidative Stress and Cellular Apoptosis

Exogenous Nucleotides Ameliorate Age-Related Decline in Testosterone in Male Senescence-Accelerated Mouse Prone-8 (SAMP8) Mice by Modulating the Local Renin–Angiotensin System Antioxidant Pathway

Ageing of the hypothalamo-pituitary-testicular axis in men

Male late-onset hypogonadism: pathogenesis, diagnosis and treatment

Improvement of Late-Onset Hypogonadism Symptoms of Fermented Morinda citrifolia Extract in TM3 Leydig and TM4 Sertoli Cells

Testosterone therapy for functional hypogonadism in middle-aged and elderly males: current evidence and future perspectives

Fertility and sexual life of men after their forties and in older age

Testosterone and the aging male: To treat or not to treat?

The Capability of L-carnitine-mediated Antioxidant on Cock During Aging: Evidence for the Improved Semen Quality and Enhanced Testicular Expressions of GnRH1, GnRHR, and Melatonin Receptors MT 1/2.

Ameliorative effects of elderberry ( Sambucus nigra L .) extract and extract-derived monosaccharide-amino acid on H 2 O 2 -induced decrease in testosterone-deficiency syndrome in a TM3 Leydig cell

Effect of Elderberry (Sambucus nigra L.) Extract Intake on Normalizing Testosterone Concentration in Testosterone Deficiency Syndrome Rat Model Through Regulation of 17β-HSD, 5α-Reductase, and CYP19A1 Expression

[Changes in Morphology and Steroidogenic Function of Aged Human Leydig Cells].

Probiotic Microbes Sustain Youthful Serum Testosterone Levels and Testicular Size in Aging Mice

Anthocyanins Prevent AAPH-Induced Steroidogenesis Disorder in Leydig Cells by Counteracting Oxidative Stress and StAR Abnormal Expression in a Structure-Dependent Manner